The ideal treatment for patients who have failed eradication of Helicobacter pylori infection after standard proton pump inhibitor-based triple therapies has still to be determined. Although either a second course of triple therapy or a quadruple therapy (proton pump inhibitor plus bismuth-based triple...
Rifabutin in combination with other agents has been proposed as a rescue therapy after Helicobacter pylori treatment failures.Although some efficacy has been observed in the treatment of tuberculosis, its use for this condition is not recommended. Side effects The adverse effects that most frequently...
rifabutin, at present the only first-line agent for prophylaxis against disseminated MAC infection inpatients with advanced human immunodeficiency virus (HIV) infection, has the potential to make a valuable contribution to the continuing attempts to preserve the quality of life of patients with AIDS. ...
Su1687 Fourth-Line Rescue Therapy With Rifabutin in Patients With Three H. pylori Eradication Failures BACKGROUND/AIMS: Optimized regimen has not yet been established for failures of multiple Helicobacter pylori (H. pylori) eradication. Hence, we aimed to ev... JP Gisbert,M Castro-Fernandez,AP...
respectively. These two regimens are main ones which we can consider as salvage therapy when first- and second-line eradication therapy fails inHelicobacter pyloritreatment. Levofloxacin-based triple therapy is known to show higher eradication rate and lower adverse events rate than bismuth quadruple th...
pylori strains resistant to multiple antibiotics, causing a decline in the effectiveness of current treatments. Recently, there has been growing interest in researching alternative treatment options for H. pylori infections that do not respond to initial therapy. Rifabutin, a rifamycin derivative ...
M1090 Rifabutin Resistance of H. pylori Isolated from Japanese PatientsA 22 year old male presented with symptoms of gastric outlet obstruction. Endoscopy showed a hypertrophic nodular lesion around the pyloric opening with pyloric stenosis. The endoscopic biopsy and histopathological examination revealed ...
Rifabutin-based tri- ple therapy after failure of Helicobacter pylori eradication treatment: preliminary experience. J Clin Gastroenterol. 2000;31:222---5.Bock H;Koop H;Lehn N.Rifabutinbased triple therapy after failure of Helicobacter pylori eradication treatment: preliminary experience[J],2000(03)....
H. pylori eradication rates for non‐ulcer dyspepsia (40%) and peptic ulcer disease (36%) were not significantly different. Conclusions : Available H. pylori eradication therapies remain very effective and compliance to guidelines achieves high success rates. Furazolidone‐based 'rescue' regimen ...
Rifabutin to the rescue in H. pylori infectionInpharma Weekly -doi:10.2165/00128413-200112760-00048NoneSpringer International PublishingInpharma Weekly